@FreedomBioInc

Next generation neuropsychiatric therapeutics biotech platform

freedombio.co
Joined July 2022
  • Tweets10
  • Following0
  • Followers88
1Media
Thanks for the feature @SFBusinessTimes - we're grateful to do this work, and to be a 50% female team! bizjournals.com/sanfrancisco…

Here are six women-led life science startups to watch

We talked to the CEOs of some of the Bay Area's most promising life science startups to find out what it takes to make it in a hyper competitive field.

bizjournals.com
206
We're so excited to partner with @hqlongevc as we work to develop effective therapeutic alternatives for people living with mental health disorders. xitter.cf/hqlongevc/status/16254…
LongeVC@hqlongevc14 Feb 2023
Today, we’re announcing our investment into cutting-edge #psychedelic treatments for #MentalHealth with @FreedomBioInc! Read more on our website: longevc.com/news-media/tpost…

LongeVC Joins Freedom Biosciences’ Funding Round For Psychedelic-Powered Mental Health Care

Company pioneering the use of ketamine and other compounds in next-generation treatments for depression, substance abuse, and other conditions

longevc.com
1
318
Dr. David Hough has joined our team as Chief Medical Officer! With nearly 17 years experience at @JanssenGlobal & a proven history of leading clinical development for revolutionary drugs like SPRAVATO® (Esketamine), he is an invaluable addition. businesswire.com/news/home/2…

Freedom Biosciences Appoints Dr. David Hough as Chief Medical Officer

Freedom Biosciences, a clinical-stage biotechnology platform developing next-generation viable and efficacious ketamine and psychedelics-based therapeutics, ...

businesswire.com
We're thrilled to share that our Co-founder & Chief Scientific Advisor Dr. John Krystal has received the @Yale Ventures Faculty Innovation Award for his work with Freedom to develop next-gen psychedelic therapeutics and make mental health care more viable and efficacious!
1
Want to know how therapeutic #ketamine is revolutionizing the stagnant field of psychiatric #medicine? Freedom Biosciences Co-founder & Chief Scientific Advisor Dr. John Krystal appeared on @TimFerrissShow to offer the most comprehensive overview. tim.blog/2022/09/30/dr-john-…

Dr. John Krystal — All Things Ketamine, The Most Comprehensive Podcast Episode Ever (#625) - The...

Interview with Dr. John Krystal on The Tim Ferriss Show podcast

tim.blog
2
Excited to share that our co-founder and CEO @dburkit was interviewed by @WSJ on the immense potential of #ketaminetherapy in the treatment of #mentalhealth conditions. wsj.com/video/investors-bet-…

Ketamine, Long-Stigmatized, Becomes a Booming Mental-Health Treatment

Clinics specializing in ketamine treatment for depression and other mood disorders have popped up across the U.S. in recent years. WSJ visits one clinic to learn why some entrepreneurs are betting...

wsj.com
We're sharing news of our launch from stealth with $10.5m in seed funding. Our mission is to bring safe and efficacious psychedelic mental health treatments to market. endpts.com/psychedelics-star…

Psychedelics startup nets more than $10M in seed funding as it looks to make a splash

As companies small and large begin to test the waters and go mainstream with a series of different psychedelics, one startup is hoping to use an expert in the ...

endpoints.news
3
1
2
9
The global #mentalhealth crisis is on the rise. Freedom Biosciences is developing next-generation #psychedelic therapeutics to meet the challenge head on.
We are led by top industry minds including Dr. John Krystal, Chair of the Department of Psychiatry at @Yale, and @dburkit, co-founder of @PsymedVentures and one of the first investors in the psychedelic therapeutics space.
1
Load more